Literature DB >> 2373093

Penicillium marneffei infection in an AIDS patient.

C M Hulshof, R A van Zanten, J F Sluiters, M E van der Ende, R S Samson, P E Zondervan, J H Wagenvoort.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2373093     DOI： 10.1007/bf01973751

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  4 in total

1.  Disseminated penicilliosis in a patient with acquired immunodeficiency syndrome.

Authors:  M R Piehl; R L Kaplan; M H Haber
Journal:  Arch Pathol Lab Med       Date:  1988-12       Impact factor: 5.534

2.  [A case of disseminated Penicillium marneffei penicilliosis in a patient with acquired immunodeficiency syndrome].

Authors:  T Ancelle; J Dupouy-Camet; F Pujol; X Nassif; L Ferradini; L Choudat; C de Bievre; B Dupont; E Drouhet; J Lapierre
Journal:  Presse Med       Date:  1988-05-28       Impact factor: 1.228

3.  Penicillosis marneffei: serological and exoantigen studies.

Authors:  A S Sekhon; J S Li; A K Garg
Journal:  Mycopathologia       Date:  1982-01-15       Impact factor: 2.574

4.  Penicilliosis marneffei in Thailand: report of five human cases.

Authors:  P Jayanetra; P Nitiyanant; L Ajello; A A Padhye; S Lolekha; V Atichartakarn; P Vathesatogit; B Sathaphatayavongs; R Prajaktam
Journal:  Am J Trop Med Hyg       Date:  1984-07       Impact factor: 2.345
  4 in total
  9 in total

Review 1.  Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects.

Authors:  Nongnuch Vanittanakom; Chester R Cooper; Matthew C Fisher; Thira Sirisanthana
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

2.  Restriction endonuclease analysis of Penicillium marneffei.

Authors:  N Vanittanakom; C R Cooper; S Chariyalertsak; S Youngchim; K E Nelson; T Sirisanthana
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

3.  Immunoperoxidase staining for identification of Aspergillus species in routinely processed tissue sections.

Authors:  P E Verweij; F Smedts; T Poot; P Bult; J A Hoogkamp-Korstanje; J F Meis
Journal:  J Clin Pathol       Date:  1996-10       Impact factor: 3.411

4.  Pulmonary penicillosis marneffei: report of the first imported case in Canada.

Authors:  A S Sekhon; L Stein; A K Garg; W A Black; J D Glezos; C Wong
Journal:  Mycopathologia       Date:  1994-10       Impact factor: 2.574

5.  Rat monoclonal antibodies against Aspergillus galactomannan.

Authors:  D Stynen; J Sarfati; A Goris; M C Prévost; M Lesourd; H Kamphuis; V Darras; J P Latgé
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

6.  Treatment and serological studies of an Italian case of penicilliosis marneffei contracted in Thailand by a drug addict infected with the human immunodeficiency virus.

Authors:  M A Viviani; A M Tortorano; G Rizzardini; T Quirino; L Kaufman; A A Padhye; L Ajello
Journal:  Eur J Epidemiol       Date:  1993-01       Impact factor: 8.082

7.  In vitro sensitivity of Penicillium marneffei and Pythium insidiosum to various antifungal agents.

Authors:  A S Sekhon; A A Padhye; A K Garg
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

8.  Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens.

Authors:  K Supparatpinyo; K E Nelson; W G Merz; B J Breslin; C R Cooper; C Kamwan; T Sirisanthana
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

9.  First case report of Talaromyces marneffei infection in HIV-infected patient in the city of Ouagadougou (Burkina Faso).

Authors:  Kiswendsida Thierry Guiguemde; Patindoilba Marcel Sawadogo; Adama Zida; Mamadou Cisse; Ibrahim Sangare; Sanata Bamba
Journal:  Med Mycol Case Rep       Date:  2019-09-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.